General form of registration statement for all companies including face-amount certificate companies

Consolidated Balance Sheets

v2.4.0.8
Consolidated Balance Sheets (USD $)
Jun. 30, 2013
Dec. 31, 2012
Dec. 31, 2011
Current Assets:      
Cash and cash equivalents $ 5,650,328 $ 5,618,669 $ 5,703,798
R&D reimbursement receivable       237,834
Prepaid expenses and other current assets 84,270 167,143 5,384
Deferred financing costs, net of accumulated amortization       252,248
Total Current Assets 5,734,598 5,785,812 6,199,264
Property and equipment, net of accumulated depreciation    3,010 1,233
Total Assets 5,734,598 5,788,822 6,200,497
Current Liabilities:      
Accounts payable and accrued expenses 793,630 897,044 644,511
Accounts payable and accrued expenses - related party 31,185 31,185   
Notes payable 36,950 140,000   
Convertible notes payable, net of unamortized discount       124,363
Derivative liabilities 2,957,977 3,574,958 4,439,613
Total Current Liabilities 3,819,742 4,643,187 5,208,487
Total Liabilities 3,819,742 4,643,187  
Commitments and contingencies         
Stockholders' Equity:      
Preferred stock value         
Common stock value 235,844 213,916 136,648
Additional paid-in capital 60,895,513 56,675,182 48,237,620
Deficit accumulated during the development stage (59,216,501) (55,743,463) (47,382,258)
Total Stockholders' Equity 1,914,856 (1,145,635) 992,010
Total Liabilities and Stockholders' Equity $ 5,734,598 $ 5,788,822 $ 6,200,497